FDA Withdraws Approvals For Advicor, Simcor At Request Of Manufacturer AbbVie
(Notice available. Document #28-160421-011X.)
The FDA made the announcement in a notice published in the Federal Register.
Advicor is a combination of the prescription cholesterol drug lovastatin and extended-release niacin. Simcor is a combination of the prescription cholesterol drug simvastatin and extended-release niacin.
Advicor was approved to treat primary...
To view the full article, register now.